Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele
Andrea J. Korecki, View ORCID ProfileJack W. Hickmott, Siu Ling Lam, Lisa Dreolini, View ORCID ProfileAnthony Mathelier, Oliver Baker, Claudia Kuehne, View ORCID ProfileRussell J. Bonaguro, Jillian Smith, Chin-Vern Tan, Michelle Zhou, View ORCID ProfileDaniel Goldowitz, View ORCID ProfileJan M. Deussing, A. Francis Stewart, View ORCID ProfileWyeth W. Wasserman, Robert A. Holt and View ORCID ProfileElizabeth M. Simpson
Genetics April 1, 2019 vol. 211 no. 4 1155-1177; https://doi.org/10.1534/genetics.119.301984
Open Access
Andrea J. Korecki
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Jack W. Hickmott
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Siu Ling Lam
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Lisa Dreolini
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
Anthony Mathelier
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Oliver Baker
§Genomics, BIOTEC, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Germany
Claudia Kuehne
**Max Planck Institute of Psychiatry, Munich 80804, Germany
Russell J. Bonaguro
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Jillian Smith
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
Chin-Vern Tan
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Michelle Zhou
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Daniel Goldowitz
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Jan M. Deussing
**Max Planck Institute of Psychiatry, Munich 80804, Germany
A. Francis Stewart
§Genomics, BIOTEC, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Germany
Wyeth W. Wasserman
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Robert A. Holt
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
††Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
Elizabeth M. Simpson
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
‡‡Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia V5Z 3N9, Canada
§§Department of Psychiatry, University of British Columbia, Vancouver, British Columbia V6T 2A1, Canada

Article Information
vol. 211 no. 4 1155-1177
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 20, 2018
- Accepted February 11, 2019
- Published online April 9, 2019.
Article Versions
- Previous version (February 14, 2019 - 14:04).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 by the Genetics Society of America Available freely online through the author-supported open access option.
Author Information
- Andrea J. Korecki*,
- Jack W. Hickmott*,†,
- Siu Ling Lam*,
- Lisa Dreolini‡,
- Anthony Mathelier*,1,
- Oliver Baker§,2,
- Claudia Kuehne**,
- Russell J. Bonaguro*,
- Jillian Smith‡,
- Chin-Vern Tan*,
- Michelle Zhou*,
- Daniel Goldowitz*,†,
- Jan M. Deussing**,
- A. Francis Stewart§,
- Wyeth W. Wasserman*,†,
- Robert A. Holt†,‡,†† and
- Elizabeth M. Simpson*,†,‡‡,§§,3
- *Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
- †Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
- ‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
- §Genomics, BIOTEC, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Germany
- **Max Planck Institute of Psychiatry, Munich 80804, Germany
- ††Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
- ‡‡Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia V5Z 3N9, Canada
- §§Department of Psychiatry, University of British Columbia, Vancouver, British Columbia V6T 2A1, Canada
- ↵3Corresponding author: The Centre for Molecular Medicine and Therapeutics, University of British Columbia, 3020–980 West 28th Ave., Vancouver, BC V5Z 4H4, Canada. E-mail: simpson{at}cmmt.ubc.ca
Statistics from Altmetric.com
Article usage
PUBLICATION INFORMATION
SUBJECTS
ARTICLE CLASSIFICATION
Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele
Andrea J. Korecki, View ORCID ProfileJack W. Hickmott, Siu Ling Lam, Lisa Dreolini, View ORCID ProfileAnthony Mathelier, Oliver Baker, Claudia Kuehne, View ORCID ProfileRussell J. Bonaguro, Jillian Smith, Chin-Vern Tan, Michelle Zhou, View ORCID ProfileDaniel Goldowitz, View ORCID ProfileJan M. Deussing, A. Francis Stewart, View ORCID ProfileWyeth W. Wasserman, Robert A. Holt and View ORCID ProfileElizabeth M. Simpson
Genetics April 1, 2019 vol. 211 no. 4 1155-1177; https://doi.org/10.1534/genetics.119.301984
Open Access
Andrea J. Korecki
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Jack W. Hickmott
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Siu Ling Lam
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Lisa Dreolini
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
Anthony Mathelier
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Oliver Baker
§Genomics, BIOTEC, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Germany
Claudia Kuehne
**Max Planck Institute of Psychiatry, Munich 80804, Germany
Russell J. Bonaguro
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Jillian Smith
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
Chin-Vern Tan
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Michelle Zhou
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Daniel Goldowitz
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Jan M. Deussing
**Max Planck Institute of Psychiatry, Munich 80804, Germany
A. Francis Stewart
§Genomics, BIOTEC, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Germany
Wyeth W. Wasserman
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Robert A. Holt
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
††Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
Elizabeth M. Simpson
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
‡‡Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia V5Z 3N9, Canada
§§Department of Psychiatry, University of British Columbia, Vancouver, British Columbia V6T 2A1, Canada
Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele
Andrea J. Korecki, View ORCID ProfileJack W. Hickmott, Siu Ling Lam, Lisa Dreolini, View ORCID ProfileAnthony Mathelier, Oliver Baker, Claudia Kuehne, View ORCID ProfileRussell J. Bonaguro, Jillian Smith, Chin-Vern Tan, Michelle Zhou, View ORCID ProfileDaniel Goldowitz, View ORCID ProfileJan M. Deussing, A. Francis Stewart, View ORCID ProfileWyeth W. Wasserman, Robert A. Holt and View ORCID ProfileElizabeth M. Simpson
Genetics April 1, 2019 vol. 211 no. 4 1155-1177; https://doi.org/10.1534/genetics.119.301984
Open Access
Andrea J. Korecki
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Jack W. Hickmott
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Siu Ling Lam
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Lisa Dreolini
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
Anthony Mathelier
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Oliver Baker
§Genomics, BIOTEC, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Germany
Claudia Kuehne
**Max Planck Institute of Psychiatry, Munich 80804, Germany
Russell J. Bonaguro
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Jillian Smith
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
Chin-Vern Tan
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Michelle Zhou
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Daniel Goldowitz
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Jan M. Deussing
**Max Planck Institute of Psychiatry, Munich 80804, Germany
A. Francis Stewart
§Genomics, BIOTEC, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Germany
Wyeth W. Wasserman
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Robert A. Holt
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
‡Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada
††Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
Elizabeth M. Simpson
*Centre for Molecular Medicine and Therapeutics at BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
†Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
‡‡Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia V5Z 3N9, Canada
§§Department of Psychiatry, University of British Columbia, Vancouver, British Columbia V6T 2A1, Canada